Development and Validation of a Stability-Indicating RP-HPLC Method for Edaravone Quantification
{{output}}
Edaravone is used to treat motor neurone disease (MND) by slowing disease progression and prolonging survival time. Currently, it is available as an IV infusion (Radicava®, Jersey City, NJ, USA) and an oral liquid suspension (Radicava ORS®, Jersey City, NJ, ... ...
